Co-morbidity between posttraumatic stress disorder (PTSD) and substance use disorders (SUD) is high and there is a need for empirically validated treatments designed to address PTSD among SUD patients. One effective PTSD treatment that may be useful in treating PTSD-SUD is exposure therapy. This paper reviews the relationship between comorbid PTSD and SUD, the basics of exposure therapy for PTS...

this workshop is an evidence-based cognitive behavioral therapy (cbt) training for mental health professionals and counselling graduate students in group therapy for anxiety disorders. the “transdiagnostic” approach is gaining widespread acceptance because it enables therapists to treat a variety of anxiety disorders using a common group protocol. training will focus specifically on delivering ...

Introduction Post-traumatic stress disorder (PTSD) is a debilitating affecting approximately 6% of the population. Current treatments have been shown to efficaciously reduce symptom burden between 30%-50%. However, due high intensity treatment over long period time. drop-out rates are as 50%. Objectives Assess effect one-time ketamine infusion in subanasthetic dosage on PTSD psychotherapy feasi...

[no abstract available]

In this article, we are collectively presenting case reports of 15 patients who developed pigmentary changes of the skin and mucus membrane during the course of chloroquine therapy for connective tissue disorders. These female patients developed hyper pigmentation of the skin, largely on the exposed parts of the body. The pigmentary changes varied from brownish/ grayish/ bluish-black in color, ...